Medartis Holding AG
MDRSFOTCHealthcare● Active
$115.00
+$0.00(+0.00%)
Market Cap$1.4B
P/E Ratio—
52W High$115
52W Low$66.68
Medartis Holding AG (MDRSF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MDRSF · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 17, 2026EPS Actual
$1.00
Revenue
$0.18B
Est. $0.18B · +2.7%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 17, 2026
After Market Close
▲ Beat Revenue
MDRSF reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 18, 2026 | — | — | — | — | $0.19B | — |
| ◌ Q1 FY2026 | Mar 17, 2026 | — | — | — | — | — | — |
| — Q1 FY2026 | Mar 17, 2026 | — | $1.00 | — | $0.18B | $0.18B | +2.7% |
| ◌ Q1 FY2025 | Mar 18, 2025 | — | — | — | $0.12B | $0.13B | -2.5% |
| — Q4 FY2024 | Dec 31, 2024 | — | $0.08 | — | $0.12B | — | — |
| ◌ Q4 FY2024 | Nov 20, 2024 | — | — | — | — | — | — |
| — Q3 FY2024 | Aug 20, 2024 | — | $0.21 | — | $0.12B | $0.13B | -2.0% |
| ◌ Q2 FY2024 | May 15, 2024 | — | — | — | $0.13B | $0.13B | +0.6% |
Q3 FY2026
Aug 18, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 17, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 17, 2026
EPS Actual
$1.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.18B
Q1 FY2025
Mar 18, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
$0.12B
Q4 FY2024
Dec 31, 2024
EPS Actual
$0.08
EPS Est.
—
EPS Surpr.
—
Revenue
$0.12B
Q4 FY2024
Nov 20, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 20, 2024
EPS Actual
$0.21
EPS Est.
—
EPS Surpr.
—
Revenue
$0.12B
Q2 FY2024
May 15, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
$0.13B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Mar 17, 2026 | — | $115.00 | $115.00 | +0.00% |
| — Q4 FY2024 | Dec 31, 2024 | — | $66.68 | $66.68 | +0.00% |
| — Q3 FY2024 | Aug 20, 2024 | — | $78.99 | $78.99 | +0.00% |
| — Q4 FY2023 | Dec 31, 2023 | — | $77.96 | $84.10 | +7.88% |
| — Q2 FY2023 | Jun 30, 2023 | — | $77.96 | $84.10 | +7.88% |
| — Q4 FY2022 | Dec 31, 2022 | — | $59.00 | $59.00 | +0.00% |
Q1 FY2026+0.00%
Report Date
Mar 17, 2026
EPS Beat/Miss
—
Price Before
$115.00
Price After
$115.00
Q4 FY2024+0.00%
Report Date
Dec 31, 2024
EPS Beat/Miss
—
Price Before
$66.68
Price After
$66.68
Q3 FY2024+0.00%
Report Date
Aug 20, 2024
EPS Beat/Miss
—
Price Before
$78.99
Price After
$78.99
Q4 FY2023+7.88%
Report Date
Dec 31, 2023
EPS Beat/Miss
—
Price Before
$77.96
Price After
$84.10
Q2 FY2023+7.88%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$77.96
Price After
$84.10
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$59.00
Price After
$59.00
Beat Rate0 / 6 quarters
Largest Move+7.88% (Q4 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MDRSF ends December
Medartis Holding AG (MDRSF) most recently reported earnings on March 17, 2026 for Q1 FY2026, posting EPS of $1.00 (in line with the analyst consensus of —). The next MDRSF earnings date is expected around September 1, 2026.
Each quarter, investors track MDRSF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MDRSF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MDRSF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MDRSF earnings · 4 questionsMedartis Holding AG's next earnings report is expected around September 1, 2026. MDRSF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MDRSF historically reports after market close (AMC).
MDRSF earnings datewhen is MDRSF earningsMDRSF next earnings datewhen does MDRSF report earningsMDRSF earnings calendar
▸ Source: FMP · Medartis Holding AG SEC filings · US GAAP · Medartis Holding AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026